Clinical trial Recruiting at 1 site Interventional Ages 18 to 40 Women only

PIEB versus CEI for epidural labor pain relief

Official title: Comparison of Continuous Epidural Infusion vs. Programmed Intermittent Epidural Bolus Combined With Patient-Controlled Epidural Analgesia for Labor Pain Relief: A Randomized Controlled Trial

Run by Da Nang Family General Hospital · NCT07395934 · Data updated 2026-11-12

This trial will test whether programmed intermittent epidural boluses (PIEB) or a continuous epidural infusion (CEI), each combined with patient-controlled epidural analgesia (PCEA), works better for pain relief during labor in women having vaginal delivery.

Quick facts

Study typeInterventional
Ages18 Years to 40 Years
SexWomen only
Enrollment60 (estimated)
SponsorDa Nang Family General Hospital
Academic / other
Locations1 site (Da Nang)
StatusRecruiting
StartedJuly 30, 2025
Main results expectedAugust 30, 2026
Study endsAugust 30, 2026
Registry record updatedFebruary 9, 2026
Trial IDNCT07395934 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are healthy term pregnant women aged 18–40 (ASA II) with singleton vertex pregnancies in active labor planning vaginal delivery and no contraindications to epidural anesthesia.

Probably not a fit

Women with contraindications to epidural anesthesia, allergy to ropivacaine or fentanyl, high‑risk pregnancies (e.g., preeclampsia, placenta previa), fetal distress, or who require immediate cesarean delivery are unlikely to benefit from this protocol.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This prospective, randomized controlled trial at Family General Hospital, Da Nang will randomize 60 term parturients to receive either PIEB or CEI maintenance after a standardized initial epidural bolus of 10 mL 0.1% ropivacaine with 2 mcg/mL fentanyl. The PIEB arm receives automated 8 mL boluses every 60 minutes starting one hour after induction, while the CEI arm receives a continuous infusion of 8 mL/hour; both arms have access to PCEA delivering 5 mL boluses with a 10‑minute lockout and a 20 mL/hour limit. Rescue analgesia is provided by a 5 mL manual bolus if pain (VAS) remains greater than 4 after two consecutive PCEA demands. Primary outcomes include VAS pain scores, total anesthetic consumption, maternal satisfaction, and neonatal Apgar scores to compare analgesic quality, drug use, and motor preservation.

Why it matters

Potential benefit: If successful, the PIEB approach could provide better pain relief with lower local anesthetic use and better preservation of maternal motor function compared with continuous infusion.

How similar studies have gone: Prior randomized studies have shown PIEB can reduce local anesthetic consumption and sometimes improve analgesia compared with CEI in labor, though results vary between settings.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Parturients indicated for labor analgesia for vaginal delivery via epidural anesthesia.
* Age from 18 to 40 years.
* Physical status: ASA II.
* Singleton pregnancy, full-term, vertex presentation in labor.
* Indication for vaginal delivery.
* No contraindications to epidural anesthesia.
* Agreement to participate in the research and signed written informed consent.

Exclusion Criteria:

* Contraindications to epidural analgesia.
* History of allergy to local anesthetics (Ropivacaine) or opioids (Fentanyl).
* High-risk pregnancies: Preeclampsia, placenta previa, placental abruption.
* Fetal distress or fetal abnormalities.
* Chronic use of analgesic drugs or neurological/psychiatric disorders.
* Parturients who refuse to participate or request to withdraw from the research.

Where it's running

  • Family General Hospital
    Da Nang, Vietnam
    Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.